Fairvalue-Calculator Fairvalue-Calculator
EN DE

Corentec Co (104540) Fair Value & Analysis

Healthcare · KR · Market cap 54.9B KRW

Price3,950 KRW
Fair Value10,770 KRW
Upside+172.7%
Quality86/100
Evidence: Medium Range 8,078 KRW – 13,463 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Corentec Co (104540) currently trades at 3,950 KRW, while our model-based Fair Value estimate is 10,770 KRW — implying the stock looks roughly 172.7% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, including LCfit HTO plate systems and Optirad volar plate system. Corentec Co., Ltd. was founded in 2000 and is headquartered in Cheonan-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Corentec Co (104540) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 10,770 KRW versus a price of 3,950 KRW — about +173% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 104540?
Our 21-model fair value for Corentec Co is 10,770 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 3,950 KRW.
What is the quality score of 104540?
Corentec Co has a Quality Score of 86/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.